SCHEMBL30751356

SCHEMBL30751356

NC(=O)c1ncnc2nc(C3CCCC3)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PBK Q96KB5 5/20 0.40
▸ ADORA3 P0DMS8 5/20 0.39
▸ ADORA2A P29274 5/20 0.39
▸ ADORA1 P30542 4/20 0.39
▸ ADORA2B P29275 4/20 0.39
▸ PARP1 P09874 6/20 0.37
▸ HPGD P15428 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30751343 0.87 ADORA1 (0.42) PBKADORA3ADORA2AADORA1ADORA2B
SCHEMBL30751437 0.79 PARP1 (0.51) PARP1
SCHEMBL6467180 0.77 ADORA1 (0.44) PBKADORA3ADORA2AADORA1ADORA2B
SCHEMBL21174272 0.73 NPC1 (0.44) HPGDLMNACYP1A2CYP3A4SMN1; SMN2
SCHEMBL31456919 0.73 LMNA (0.37) ADORA3ADORA2AADORA1ADORA2BPARP1
SCHEMBL31456923 0.72 ALDH1A1 (0.46) ADORA2AADORA1ADORA2BHPGDLMNA
SCHEMBL30751370 0.71 CALCA (0.40) PBKADORA2AADORA1ADORA2BMAPK1
SCHEMBL11480013 0.70 PARP1 (0.39) ADORA2AADORA2BPARP1HPGDSMN1; SMN2
SCHEMBL21174309 0.70 PBK (0.38) PBKADORA2AADORA1ADORA2B
SCHEMBL30751428 0.69 PBK (0.34) PBKPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119654324-A Novel compounds as hypoxia inducible factor 1 (HIF-1) inhibitors or Vascular Endothelial Growth Factor (VEGF) inhibitors and pharmaceutical compositions comprising the same 株式会社次代生物科学 2025-03-18 — — CN claimed
CN-119654324-A Novel compounds as hypoxia inducible factor 1 (HIF-1) inhibitors or Vascular Endothelial Growth Factor (VEGF) inhibitors and pharmaceutical compositions comprising the same 株式会社次代生物科学 2025-03-18 — — CN disclosed
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 — — WO disclosed
Send feedback